Тезис Предпросмотр

ISO 5840-3:2013 outlines an approach for verifying/validating the design and manufacture of a transcatheter heart valve substitute through risk management. The selection of appropriate verification/validation tests and methods are to be derived from the risk assessment. The tests may include those to assess the physical, chemical, biological and mechanical properties of heart valve substitutes and of their materials and components. The tests can also include those for preclinical in vivo evaluation and clinical evaluation of the finished heart valve substitute.

ISO 5840-3:2013 defines operational conditions and performance requirements for transcatheter heart valve substitutes where adequate scientific and/or clinical evidence exists for their justification.

ISO 5840-3:2013 is applicable to all devices intended for implantation in human hearts as a transcatheter heart valve substitute.

ISO 5840-3:2013 is applicable to both newly developed and modified transcatheter heart valve substitutes and to the accessory devices, packaging and labelling required for their implantation and for determining the appropriate size of heart valve substitute to be implanted.


Общая информация

  • Текущий статус :  Published
    Дата публикации : 2013-03
  • Версия : 1
    Число страниц : 105
  • :
    ISO/TC 150/SC 2
    Cardiovascular implants and extracorporeal systems
  • 11.040.40
    Implants for surgery, prosthetics and orthotics

Приобрести данный стандарт

Формат Язык
PDF + ePub
Бумажный
PDF
  • CHF198

Жизненны цикл

Стандарт, который пересматривается каждые 5 лет



Изменения / Исправления

  • Сейчас на стадии пересмотра
    ISO 5840-3:2013
  • Будет заменено
    ISO/DIS 5840-3

Появились вопросы?

Ознакомьтесь с FAQ

Работа с клиентами
+41 22 749 08 88

Часы работы:
Понедельник – пятница: 09:00-12:00, 14:00-17:00 (UTC+1)

Будьте в курсе актуальных новостей ИСО

Подписывайтесь на наши новости, обзоры, а также на информацию о продуктах